A L Rich1, A Khakwani2, C M Free3, L J Tata2, R A Stanley4, M D Peake4, R B Hubbard2, D R Baldwin5. 1. From the Nottingham University Hospitals and anna.rich@nottingham.ac.uk. 2. Epidemiology and Public Health, Clinical Sciences Building, City Campus, Hucknall Road, Nottingham NG5 1PB, UK. 3. University Hospitals of Leicester, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK and. 4. Health and Social Care Information Centre (HSCIC), 1, Trevelyan Square, Leeds LS1 6AE, UK. 5. From the Nottingham University Hospitals and.
Abstract
BACKGROUND: Non-small cell lung cancer (NSCLC) in young adults is a rare but devastating illness with significant socioeconomic implications, and studies of this patient subgroup are limited. AIM: This study employed the National Lung Cancer Audit to compare the clinical features and survival of young adults with NSCLC with the older age groups. DESIGN: A retrospective cohort review using a validated national audit dataset. METHODS: Data were analysed for the period between 1 January 2004 and 31 December 2011. Young adults were defined as between 18 and 39 years, and all others were divided into decade age groups, up to the 80 years and above group. We performed logistic and Cox regression analyses to assess clinical outcomes. RESULTS: Of a total of 1 46 422 patients, 651 (0.5%) were young adults, of whom a higher proportion had adenocarcinoma (48%) than in any other age group. Stage distribution of NSCLC was similar across the age groups and 71% of young patients had stage IIIb/IV. Performance status (PS) was 0-1 for 85%. Young adults were more likely to have surgery and chemotherapy compared with the older age groups and had better overall and post-operative survival. The proportion with adenocarcinoma, better PS and that receiving surgery or chemotherapy diminished progressively with advancing decade age groups. CONCLUSION: In our cohort of young adults with NSCLC, the majority had good PS despite the same late-stage disease as older patients. They were more likely to have treatment and survive longer than older patients.
BACKGROUND:Non-small cell lung cancer (NSCLC) in young adults is a rare but devastating illness with significant socioeconomic implications, and studies of this patient subgroup are limited. AIM: This study employed the National Lung Cancer Audit to compare the clinical features and survival of young adults with NSCLC with the older age groups. DESIGN: A retrospective cohort review using a validated national audit dataset. METHODS: Data were analysed for the period between 1 January 2004 and 31 December 2011. Young adults were defined as between 18 and 39 years, and all others were divided into decade age groups, up to the 80 years and above group. We performed logistic and Cox regression analyses to assess clinical outcomes. RESULTS: Of a total of 1 46 422 patients, 651 (0.5%) were young adults, of whom a higher proportion had adenocarcinoma (48%) than in any other age group. Stage distribution of NSCLC was similar across the age groups and 71% of young patients had stage IIIb/IV. Performance status (PS) was 0-1 for 85%. Young adults were more likely to have surgery and chemotherapy compared with the older age groups and had better overall and post-operative survival. The proportion with adenocarcinoma, better PS and that receiving surgery or chemotherapy diminished progressively with advancing decade age groups. CONCLUSION: In our cohort of young adults with NSCLC, the majority had good PS despite the same late-stage disease as older patients. They were more likely to have treatment and survive longer than older patients.
Authors: Marco Galvez-Nino; Rossana Ruiz; Joseph A Pinto; Katia Roque; Raul Mantilla; Luis E Raez; Luis Mas Journal: Lung Date: 2019-11-26 Impact factor: 2.584
Authors: Aamir Khakwani; Ruth H Jack; Sally Vernon; Rosie Dickinson; Natasha Wood; Susan Harden; Paul Beckett; Ian Woolhouse; Richard B Hubbard Journal: ERJ Open Res Date: 2017-07-21